Evaluation of a Multi-professional Breathlessness Service for Patients With Breathlessness Due to Any Advanced Disease (BreathEase)
Randomised Controlled Trial Testing the Effectiveness of a New Multi-professional Breathlessness sErvice for Patients With Any Advanced diSease Against Usual Care (BreathEase)
Sponsor: Helmholtz Zentrum München
A NA clinical study on Breathlessness and COPD, this trial is completed. The trial is conducted by Helmholtz Zentrum München and has accumulated 8 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Sep 2019 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Mar 2019 — Sep 2019 [monthly]
Active Not Recruiting NA
Status: Unknown Status → Active Not Recruiting
▶ Show 3 earlier versions
-
Oct 2018 — Mar 2019 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2018 — Oct 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Mar 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Helmholtz Zentrum München
- King's College London
- Ludwig-Maximilians - University of Munich
- University Hospital Munich
- University of Cambridge
For direct contact, visit the study record on ClinicalTrials.gov .